Anidulafungin (Slovenian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Anidulafungin" in Slovenian language version.

refsWebsite

Global rank Slovenian rank

4nih.gov

4^th place

8^th place

3doi.org

2^nd place

5^th place

1cbz.si

low place

607^th place

1who.int

195^th place

64^th place

1pfizer.com

low place

1termania.net

low place

34^th place

1worldcat.org

5^th place

10^th place

1handle.net

102^nd place

416^th place

1europa.eu

68^th place

28^th place

cbz.si

http://www.cbz.si/cbz/bazazdr2.nsf/Search?SearchView&Query=(%5BSEZNAMUCINKNAZIV%5D=_Anidulafungin*)&SearchOrder=4&SearchMax=301 Centralna baza zdravil, vpogled: 27. 6. 2022.

doi.org

Grau, Santiago; Azanza, Jose Ramon; Ruiz, Isabel; Vallejo, Carlos; Mensa, Josep; Maertens, Johan; Heinz, Werner J.; Barrueta, Jon Andoni; Peral, Carmen (1. januar 2017). »Cost-effectiveness analysis of combination antifungal therapy with voriconazole and anidulafungin versus voriconazole monotherapy for primary treatment of invasive aspergillosis in Spain«. ClinicoEconomics and Outcomes Research. 9: 39–47. doi:10.2147/CEOR.S122177. PMC 5221484. PMID 28115858.
Zida, A.; Bamba, S.; Yacouba, A.; Ouedraogo-Traore, R.; Guiguemdé, R. T. (1. marec 2017). »Anti-Candida albicans natural products, sources of new antifungal drugs: A review«. Journal de Mycologie Médicale. 27 (1): 1–19. doi:10.1016/j.mycmed.2016.10.002. ISSN 1773-0449. PMID 27842800.
Denning DW (1997). »Echinocandins and pneumocandins - a new antifungal class with a novel mode of action«. J Antimicrob Chemother. 40 (5): 611–614. doi:10.1093/jac/dkf045. PMID 9421307.

europa.eu

ema.europa.eu

https://www.ema.europa.eu/en/documents/product-information/ecalta-epar-product-information_sl.pdf Povzetek glavnih značilnosti zdravila Ecalta, vpogled: 27. 6. 2022.

handle.net

hdl.handle.net

World Health Organization (2021). World Health Organization model list of essential medicines: 22nd list (2021). Ženeva: Svetovna zdravstvena organizacija. hdl:10665/345533. WHO/MHP/HPS/EML/2021.02.

nih.gov

pubmed.ncbi.nlm.nih.gov

Grau, Santiago; Azanza, Jose Ramon; Ruiz, Isabel; Vallejo, Carlos; Mensa, Josep; Maertens, Johan; Heinz, Werner J.; Barrueta, Jon Andoni; Peral, Carmen (1. januar 2017). »Cost-effectiveness analysis of combination antifungal therapy with voriconazole and anidulafungin versus voriconazole monotherapy for primary treatment of invasive aspergillosis in Spain«. ClinicoEconomics and Outcomes Research. 9: 39–47. doi:10.2147/CEOR.S122177. PMC 5221484. PMID 28115858.
Zida, A.; Bamba, S.; Yacouba, A.; Ouedraogo-Traore, R.; Guiguemdé, R. T. (1. marec 2017). »Anti-Candida albicans natural products, sources of new antifungal drugs: A review«. Journal de Mycologie Médicale. 27 (1): 1–19. doi:10.1016/j.mycmed.2016.10.002. ISSN 1773-0449. PMID 27842800.
Denning DW (1997). »Echinocandins and pneumocandins - a new antifungal class with a novel mode of action«. J Antimicrob Chemother. 40 (5): 611–614. doi:10.1093/jac/dkf045. PMID 9421307.

ncbi.nlm.nih.gov

Grau, Santiago; Azanza, Jose Ramon; Ruiz, Isabel; Vallejo, Carlos; Mensa, Josep; Maertens, Johan; Heinz, Werner J.; Barrueta, Jon Andoni; Peral, Carmen (1. januar 2017). »Cost-effectiveness analysis of combination antifungal therapy with voriconazole and anidulafungin versus voriconazole monotherapy for primary treatment of invasive aspergillosis in Spain«. ClinicoEconomics and Outcomes Research. 9: 39–47. doi:10.2147/CEOR.S122177. PMC 5221484. PMID 28115858.

pfizer.com

labeling.pfizer.com

»Eraxis (anidulafungin) for Injection, for Intravenous Use. Full Prescribing Information«. Roerig (Division of Pfizer, Inc.), New York, NY 10017. Pridobljeno 11. novembra 2016.

termania.net

https://www.termania.net/slovarji/slovenski-medicinski-slovar/5505974/anidulafungin?query=Anidulafungin&SearchIn=All Slovenski medicinski e-slovar, vpogled: 27. 6. 2022.

who.int

»International Nonproprietary Names for Pharmaceutical Substances (INN). Recommended International Nonproprietary names: List 43« (PDF). World Health Organization. 2000. Pridobljeno 11. novembra 2016.

worldcat.org

Zida, A.; Bamba, S.; Yacouba, A.; Ouedraogo-Traore, R.; Guiguemdé, R. T. (1. marec 2017). »Anti-Candida albicans natural products, sources of new antifungal drugs: A review«. Journal de Mycologie Médicale. 27 (1): 1–19. doi:10.1016/j.mycmed.2016.10.002. ISSN 1773-0449. PMID 27842800.